News & Updates

Disrupted delta wave activity during sleep predicts CVD, death

30 Apr 2024

Disruption of the delta wave activity while sleeping may be used to pinpoint individuals who are at heightened risk for cardiovascular disease (CVD) and CVD mortality, according to a study.

Disrupted delta wave activity during sleep predicts CVD, death

30 Apr 2024

Diltiazem carries increased risk of serious bleeding in certain AF patients

30 Apr 2024

The use of diltiazem, especially at doses exceeding 120 mg/d, appears to contribute to a heightened risk of serious bleeding compared with metoprolol in patients with atrial fibrillation (AF) who are receiving oral anticoagulant therapy, according to a retrospective cohort study.

Diltiazem carries increased risk of serious bleeding in certain AF patients

30 Apr 2024

CSR cuts angina episodes in patients with no further antianginal options

30 Apr 2024 by

In the placebo-controlled ORBITA-COSMIC* trial, an implantable coronary sinus reducer (CSR) does not increase transmural myocardial perfusion, but it reduces the frequency of angina and improves quality of life (QoL) in patients with no further antianginal options.

CSR cuts angina episodes in patients with no further antianginal options

30 Apr 2024

Higher doses of NSAID carry increased CVD risk in ankylosing spondylitis patients

26 Apr 2024

Patients with ankylosing spondylitis who are exposed to higher doses of nonsteroidal anti-inflammatory drugs (NSAIDs) appear to have an elevated risk of cardiovascular disease (CVD), according to a study.

Higher doses of NSAID carry increased CVD risk in ankylosing spondylitis patients

26 Apr 2024

SingHypertension: Primary care intervention for BP control deemed cost-effective

26 Apr 2024 by

A multicomponent intervention to control elevated blood pressure (BP) levels at the primary care level, SingHypertension, represents good value for money for reducing hypertension-related morbidity and mortality in Singapore, according to a cost-effectiveness study.

SingHypertension: Primary care intervention for BP control deemed cost-effective

26 Apr 2024

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

26 Apr 2024 by

Use of transcatheter aortic valve implantation (TAVI) does not increase the risks and contributes to a decrease in the rates of death or stroke at 1 year in patients with severe aortic stenosis when compared with surgical aortic-valve replacement (SAVR), suggests a study presented at ACC.24.

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

26 Apr 2024

Original New Drug Application Approvals by US FDA (1-15 April 2024)

26 Apr 2024

New drug applications approved by US FDA as of 1-15 April 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 April 2024)

26 Apr 2024

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

25 Apr 2024 by

Using intravascular ultrasound (IVUS) to guide stent placement in patients with acute coronary syndrome (ACS) appears to reduce the 1-year risk of target vessel failure as compared with using angiography alone, according to the results of the IVUS-ACS study.

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

25 Apr 2024

Heart pump helps prevent death after severe heart attack

25 Apr 2024 by

Patients with ST-segment elevation myocardial infarction (STEMI)-related cardiogenic shock may benefit from a significantly higher survival rate at 6 months through the routine use of a microaxial flow pump in combination with standard care as compared with standard care alone, as shown in a study presented at the recent ACC.24.

Heart pump helps prevent death after severe heart attack

25 Apr 2024

‘Inclisiran first’ strategy in ASCVD reduces LDL-C

25 Apr 2024 by

Among patients with atherosclerotic cardiovascular disease (ASCVD) who fail to achieve guideline-directed low-density lipoprotein cholesterol (LDL-C) goals despite receiving maximally tolerated statins, initiating inclisiran immediately resulted in significant reductions in LDL-C, according to the VICTORION-INITIATE trial presented at ACC.24.

‘Inclisiran first’ strategy in ASCVD reduces LDL-C

25 Apr 2024

News & Updates

Filter by Specialty:

Specialty:

Disrupted delta wave activity during sleep predicts CVD, death

Disrupted delta wave activity during sleep predicts CVD, death

Diltiazem carries increased risk of serious bleeding in certain AF patients

Diltiazem carries increased risk of serious bleeding in certain AF patients

CSR cuts angina episodes in patients with no further antianginal options

CSR cuts angina episodes in patients with no further antianginal options

Higher doses of NSAID carry increased CVD risk in ankylosing spondylitis patients

Higher doses of NSAID carry increased CVD risk in ankylosing spondylitis patients

SingHypertension: Primary care intervention for BP control deemed cost-effective

SingHypertension: Primary care intervention for BP control deemed cost-effective

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

TAVI not inferior to SAVR in low-risk patients with severe aortic stenosis

Original New Drug Application Approvals by US FDA (1-15 April 2024)

Original New Drug Application Approvals by US FDA (1-15 April 2024)

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

Intravascular ultrasound-guided stenting delivers improved outcomes for ACS patients

Heart pump helps prevent death after severe heart attack

Heart pump helps prevent death after severe heart attack

‘Inclisiran first’ strategy in ASCVD reduces LDL-C

‘Inclisiran first’ strategy in ASCVD reduces LDL-C